Aurélie Catteau

1.8k total citations
27 papers, 854 citations indexed

About

Aurélie Catteau is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Aurélie Catteau has authored 27 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Aurélie Catteau's work include Colorectal Cancer Treatments and Studies (11 papers), Cancer Immunotherapy and Biomarkers (11 papers) and BRCA gene mutations in cancer (5 papers). Aurélie Catteau is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Cancer Immunotherapy and Biomarkers (11 papers) and BRCA gene mutations in cancer (5 papers). Aurélie Catteau collaborates with scholars based in France, United Kingdom and United States. Aurélie Catteau's co-authors include Ellen Solomon, Chun‐Fang Xu, William H. Harris, Joanna R. Morris, Sjoerd Klarenbeek, Ingrid van der Heijden, Peter Green, Christiaan Klijn, Ellen Wientjens and Mark Pieterse and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Cell and Cancer Research.

In The Last Decade

Aurélie Catteau

27 papers receiving 845 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Aurélie Catteau 536 304 293 113 79 27 854
Rumana Rafiq 562 1.0× 425 1.4× 65 0.2× 88 0.8× 114 1.4× 8 759
Concetta Cuozzo 565 1.1× 97 0.3× 105 0.4× 66 0.6× 53 0.7× 6 756
Laurence Lasorsa 369 0.7× 136 0.4× 69 0.2× 176 1.6× 33 0.4× 7 580
Andrzej Wincewicz 393 0.7× 190 0.6× 49 0.2× 219 1.9× 39 0.5× 75 749
Masaaki Hamaguchi 535 1.0× 175 0.6× 182 0.6× 105 0.9× 67 0.8× 20 752
José Manuel Pacheco García 443 0.8× 430 1.4× 68 0.2× 190 1.7× 98 1.2× 27 779
Eleanor Latta 135 0.3× 214 0.7× 82 0.3× 92 0.8× 101 1.3× 19 535
Hiroyuki Arai 270 0.5× 244 0.8× 63 0.2× 81 0.7× 136 1.7× 71 734
Din‐Lii Lin 381 0.7× 212 0.7× 183 0.6× 91 0.8× 233 2.9× 13 730
Sarah J. Aitken 361 0.7× 213 0.7× 97 0.3× 302 2.7× 100 1.3× 14 785

Countries citing papers authored by Aurélie Catteau

Since Specialization
Citations

This map shows the geographic impact of Aurélie Catteau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélie Catteau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélie Catteau more than expected).

Fields of papers citing papers by Aurélie Catteau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélie Catteau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélie Catteau. The network helps show where Aurélie Catteau may publish in the future.

Co-authorship network of co-authors of Aurélie Catteau

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélie Catteau. A scholar is included among the top collaborators of Aurélie Catteau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélie Catteau. Aurélie Catteau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Antoniotti, Carlotta, Daniele Rossini, Filippo Pietrantonio, et al.. (2023). SO-28 FOLFOXIRI plus bevacizumab and atezolizumab as upfront treatment of unresectable mCRC patients: Updated and overall survival results of the phase II randomized AtezoTRIBE study. Annals of Oncology. 34. S173–S174. 2 indexed citations
2.
Wang, Fulong, Shi‐Xun Lu, Di Cao, et al.. (2023). Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer. OncoImmunology. 12(1). 2161167–2161167. 9 indexed citations
3.
Galon, Jérôme, Frédéric Bibeau, Laurent Greillier, et al.. (2022). Efficacy of anti-PD1/PD-L1 immunotherapy in non–small cell lung cancer is dependent upon Immunoscore IC CD8 and PD-L1 status.. Journal of Clinical Oncology. 40(16_suppl). 2509–2509. 2 indexed citations
4.
Kassambara, Alboukadel, et al.. (2022). Comparison of Immune Response Assessment in Colon Cancer by Immunoscore (Automated Digital Pathology) and Pathologist Visual Scoring. Cancers. 14(5). 1170–1170. 6 indexed citations
5.
Church, David N., Owen J. Sansom, Noori Maka, et al.. (2022). Clinical performance of Immunoscore in stage III colorectal cancer patients in the SCOT and IDEA-HORG cohorts.. Journal of Clinical Oncology. 40(4_suppl). 196–196. 2 indexed citations
6.
Kasi, Anup, Efrat Dotan, Graham M. Poage, et al.. (2021). Impact of Immunoscore on the Management of Stage II Colon Cancer Patients: A Physician Survey. Cancers. 13(21). 5467–5467. 4 indexed citations
7.
Avallone, Antonio, Alfonso De Stefano, Ugo Pace, et al.. (2020). 491P Neoadjuvant nivolumab in early stage colorectal cancer. Annals of Oncology. 31. S449–S449. 25 indexed citations
8.
Pagès, Franck, Thierry André, Julien Taı̈eb, et al.. (2019). Validation of the Immunoscore prognostic value in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France cohort study (PRODIGE-GERCOR).. Journal of Clinical Oncology. 37(15_suppl). 3513–3513. 7 indexed citations
9.
Catteau, Aurélie, Florence Monville, Sabrina Carpentier, et al.. (2014). A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma. Acta Neuropathologica Communications. 2(1). 58–58. 32 indexed citations
10.
Soria, Jean‐Charles, Javier Cortés, Christophe Massard, et al.. (2011). Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors. Annals of Oncology. 23(2). 463–471. 22 indexed citations
11.
Drost, Rinske, Peter Bouwman, Sven Rottenberg, et al.. (2011). BRCA1 RING Function Is Essential for Tumor Suppression but Dispensable for Therapy Resistance. Cancer Cell. 20(6). 797–809. 197 indexed citations
12.
Veys, Isabelle, Roberto Salgado, Aurélie Catteau, et al.. (2011). P1-07-08: PCR Genomic Grade in Breast Cancer: A New Tool for Daily Practice.. Cancer Research. 71(24_Supplement). P1–7. 1 indexed citations
13.
Osseby, Guy Victor, Olivier Rouaud, Apolline Kazémi, et al.. (2010). Transient Ischaemic Attack Mimics Revealing Focal Subarachnoid Haemorrhage. Cerebrovascular Diseases. 30(6). 597–601. 19 indexed citations
14.
Béjot, Yannick, Aurélie Catteau, Marie Caillier, et al.. (2008). Trends in Incidence, Risk Factors, and Survival in Symptomatic Lacunar Stroke in Dijon, France, From 1989 to 2006. Stroke. 39(7). 1945–1951. 64 indexed citations
15.
Whitehouse, Caroline A., Julie A. Chambers, Aurélie Catteau, & Ellen Solomon. (2003). Brca1 expression is regulated by a bidirectional promoter that is shared by the Nbr1 gene in mouse. Gene. 326. 87–96. 11 indexed citations
16.
Catteau, Aurélie & Joanna R. Morris. (2002). BRCA1 methylation: a significant role in tumour development?. Seminars in Cancer Biology. 12(5). 359–371. 82 indexed citations
17.
Catteau, Aurélie, Chun‐Fang Xu, Melissa A. Brown, et al.. (1999). Identification of a C/G polymorphism in the promoter region of the BRCA1 gene and its use as a marker for rapid detection of promoter deletions. British Journal of Cancer. 79(5-6). 759–763. 9 indexed citations
18.
Catteau, Aurélie, William H. Harris, Chun‐Fang Xu, & Ellen Solomon. (1999). Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene. 18(11). 1957–1965. 285 indexed citations
19.
Catteau, Aurélie, et al.. (1995). A population and family study of CYP1A2 using caffeine urinary metabolites. European Journal of Clinical Pharmacology. 47(5). 423–30. 38 indexed citations
20.
Wery, Didier, et al.. (1990). [Computed tomography aspects of cerebral toxoplasmosis in AIDS].. PubMed. 73(3). 162–72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rumana Rafiq Breakdown of academic impact, for papers by Concetta Cuozzo Breakdown of academic impact, for papers by Laurence Lasorsa Breakdown of academic impact, for papers by Andrzej Wincewicz Breakdown of academic impact, for papers by Masaaki Hamaguchi Breakdown of academic impact, for papers by José Manuel Pacheco García Breakdown of academic impact, for papers by Eleanor Latta Breakdown of academic impact, for papers by Hiroyuki Arai Breakdown of academic impact, for papers by Din‐Lii Lin Breakdown of academic impact, for papers by Sarah J. Aitken
Rankless by CCL
2026